After consent, participants will complete a baseline visit to confirm eligibility. If eligible, participants will be randomized into the Device Arm or the Control Arm. All participants will complete questionnaires, physical exams, blood work, and transvaginal ultrasounds. The Device Arm will receive the May Health procedure and then regular blood tests. There will be 6 follow up visits and some follow up calls through 36 months after the procedure. The Control Arm will complete regular blood tests then meet with the study team at Month 3 to either exit the study or to crossover into the Device Arm to receive the May Health procedure.